Dr Philip Maldonado, DMD | |
19025 Wileys Well Rd, Blythe, CA 92225-2287 | |
(760) 922-5300 | |
(714) 992-0759 |
Full Name | Dr Philip Maldonado |
---|---|
Gender | Male |
Speciality | Dentist |
Location | 19025 Wileys Well Rd, Blythe, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306255351 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
122300000X | Dentist | 63483 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Philip Maldonado, DMD 19025 Wileys Well Rd, Blythe, CA 92225-2287 Ph: (760) 922-5300 | Dr Philip Maldonado, DMD 19025 Wileys Well Rd, Blythe, CA 92225-2287 Ph: (760) 922-5300 |
News Archive
The Biotechnology Industry Organization (BIO) praised the Obama Administration for its new guidance, released today, that will lead to many small biotechnology companies receiving needed funding to support critical on-going research and development programs. The guidance document initiates the Therapeutic Discovery Project Program (TDPP), which was created by the Patient Protection and Affordable Care Act signed into law by President Obama on March 23.
Cyclacel Pharmaceuticals, Inc., a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases, announced today that it consummated its previously announced private placement to sell approximately $15.2 million of its units to several institutional investors, including the Special Situations Funds, for net proceeds of approximately $14.1 million after the deduction of offering expenses.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Metoprolol Tartrate Injection, USP, and expects to launch the medication soon.
Raptor Pharmaceutical Corp., today announced it has reopened enrollment in its Phase 3 clinical trial of its proprietary delayed-release oral formulation of cysteamine bitartrate in patients with nephropathic cystinosis.
Scientists say using physical barriers, such as regular hand washing and wearing masks, gloves and gowns, may be far more effective than drugs to prevent the spread of respiratory viruses such as influenza and SARS.
› Verified 3 days ago
Eric Joseph Clark, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 500 N Broadway, #4, Blythe, CA 92225 Phone: 760-922-0266 Fax: 760-922-1066 | |
Dr. Mueni Lorraine Mutinga, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 19025 Wileys Well Rd, Blythe, CA 92225 Phone: 760-922-5300 | |
Dr. Victor Khalil, Dentist Medicare: Not Enrolled in Medicare Practice Location: 19005 Wileys Well Rd, Blythe, CA 92225 Phone: 760-921-7548 | |
Mr. Carman Stuart Sutley, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 17611 S C & D Blvd, #18, Blythe, CA 92225 Phone: 760-921-2414 Fax: 760-921-2414 | |
Dr. Tiffany Elaine Wade, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 146 S Broadway, Blythe, CA 92225 Phone: 760-567-7873 | |
Hemantkumar Patel, Dentist Medicare: Not Enrolled in Medicare Practice Location: 1415 W Hobsonway, Blythe, CA 92225 Phone: 760-922-4981 Fax: 760-922-4442 |